ColgatePalmolive (CL)
(Delayed Data from NYSE)
$105.81 USD
+0.02 (0.02%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $105.82 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$105.81 USD
+0.02 (0.02%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $105.82 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Zacks News
Are You Looking for a Top Momentum Pick? Why Colgate-Palmolive (CL) is a Great Choice
by Zacks Equity Research
Does Colgate-Palmolive (CL) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights PepsiCo, General Mills and Colgate-Palmolive
by Zacks Equity Research
PepsiCo, General Mills and Colgate-Palmolive are included in this Analyst Blog.
3 Consumer Staples Stocks Investors Shouldn't Ignore
by Derek Lewis
For those interested in a more conservative approach in the near-term with a Fed decision looming, these three low-beta stocks could be great considerations. Impressively, all are coming off a recent double-beat.
Zacks.com featured highlights ColgatePalmolive, BigCommerce and Exact Sciences
by Zacks Equity Research
ColgatePalmolive, BigCommerce and Exact Sciences have been highlighted in this Screen of The Week article.
Colgate (CL) Q1 Earnings & Sales Beat Estimates, View Up
by Zacks Equity Research
On an organic basis, Colgate-Palmolive's (CL) first-quarter 2023 sales advance 10%, with improvements in all divisions and categories.
Colgate-Palmolive (CL) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.29% and 3.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Top Earnings Acceleration Stocks Worth Buying
by Tirthankar Chakraborty
Notable companies to have witnessed solid earnings acceleration as of now are ColgatePalmolive (CL), BigCommerce (BIGC) & Exact Sciences (EXAS).
Sysco Corporation (SYY) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Sysco (SYY) third-quarter results might reflect gains from the improving supply-chain efforts, and customer-oriented merchandising and marketing solutions.
Here's Why Clorox (CLX) Looks Well-Placed for Q3 Earnings Beat
by Zacks Equity Research
Clorox's (CLX) Q3 results are likely to reflect gains from strong demand, cost savings, improved productivity and pricing actions. The company's IGNITE strategy also bodes well.
Should You Buy Colgate (CL) Ahead of Earnings?
by Zacks Equity Research
Colgate (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Church & Dwight (CHD) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 11.84% and 5.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's How Colgate (CL) is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Colgate's (CL) first-quarter 2023 sales are likely to have gained from innovation, brand strength, focus on premiumization and expansion efforts.
Don't Overlook These Top-Rated Stocks Before Earnings
by Shaun Pruitt
Two stocks that are worthy of investors' consideration going into their first-quarter earnings reports on Friday, April 28 are Colgate-Palmolive (CL) and WisdomTree (WT).
Here's How FEMSA (FMX) is Placed Just Before Q1 Earnings
by Zacks Equity Research
FEMSA (FMX) Q1 results are expected to reflect gains from strong demand trends, digital growth, strong segmental results and expansion initiatives.
Here's How Newell (NWL) is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Despite tough environment, reduced inventory and inflationary pressures, productivity and efficiency initiatives and digital growth are likely to have aided Newell's (NWL) Q1 earnings.
What's in Store for Service Corporation (SCI) in Q1 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) first-quarter 2023 performance is likely to have been adversely impacted by rising inflationary pressure. Strength in the preened cemetery sales has been an upside.
Lumen (LUMN) to Report Q1 Earnings: Here's What to Expect
by Zacks Equity Research
Lumen's (LUMN) Q1 performance is likely to have been affected by supply-chain woes, macroeconomic weakness and dissynergies from the sale of ILEC and Latin America businesses
Factors Likely to Influence Boston Beer's (SAM) Q1 Earnings
by Zacks Equity Research
Boston Beer's (SAM) Q1 results are expected to reflect significant impacts of a slowdown in hard seltzer trends, increased supply-chain costs and higher operating expenses.
Clorox (CLX) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VeriSign (VRSN) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
VeriSign (VRSN) first-quarter performance is expected to have benefited from growing Internet consumption. However, ongoing weakness in global macroeconomic conditions might have been a concern.
How Keurig Dr Pepper's (KDP) Looks Just Ahead of Q1 Earnings
by Zacks Equity Research
Although inflation has been concerning, continued strength in Packaged Beverages and strong in-market performances are likely to have aided Keurig Dr Pepper's (KDP) Q1 performance.
Church & Dwight (CHD) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2023 results are likely to reflect profit from strong consumer demand. It is likely to reflect benefits from strong pricing action incurred to counter inflation.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results benefit from robust pricing and a favorable mix, along with strength across its segments.
Colgate-Palmolive (CL) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?